BeyondSpring BYSI
NASDAQ BYSI
$0.72 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

BeyondSpring (BYSI) Net Margin (2020 - 2025)

BeyondSpring (BYSI) posted Net Margin of 76.96% for Q3 2025, up 27.77% sequentially from 106.55% in Q3 2024, and up 2959.0% YoY from 2.52% in Q3 2024.

BeyondSpring (BYSI) Net Margin (2020 - 2025) Analysis & Trends

BeyondSpring has reported Net Margin for 4 years, with the latest figure at 76.96% in Q3 2025.

  • Quarterly Net Margin rose 2959.0% year-over-year to 76.96% in Q3 2025, while the trailing twelve-month figure through Mar 2026 was 439.23% (down 21384.0% YoY) and the FY2022 annual result came in at 2111.92%, up 166936.0% from the prior year.
  • Net Margin advanced to 76.96% in Q3 2025 per BYSI's latest filing, from 106.55% in the prior quarter.
  • Over five years, Net Margin peaked at 1898.22% in Q4 2021 and troughed at 5977.15% in Q3 2021.
  • A 3-year average of 2551.48% and a median of 2633.6% in 2024 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2021 and 2025: Net Margin surged 466100 bps in 2021, then soared 2959 bps in 2025.
  • Over 3 years, Net Margin stood at 1898.22% in 2021, then slumped by 106 bps to 106.55% in 2024, then increased by 28 bps to 76.96% in 2025.
  • According to Business Quant data, Net Margin over the past three periods registered 76.96%, 106.55%, and 1898.22% for Q3 2025, Q3 2024, and Q4 2021 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 30.23%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 31.16%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -539.31%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 13.90%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 12.74%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -16.51%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -3.12%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 12.09%
10 BeyondSpring 29.85 Mn 29.85 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -76.96%
Sep 30, 2024 -106.55%
Dec 31, 2021 1,898.22%
Sep 30, 2021 -5,977.15%
Jun 30, 2021 -5,885.80%
Mar 31, 2021 -5,160.65%
Dec 31, 2020 -2,762.78%